At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department
In Brief
An observational study for Angioedema. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Angiotensin-converting enzyme inhibitor ACEi induced angioedema ACEi-AE is defined as physical swelling of the deep skin layers or mucous membranes due to increased vascular permeability and leakage of fluid into the interstitial space caused while taking an ACEi
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAngioedema
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
Primary CompletionAug 2023
First PostedOct 2023
TodayJul 2026
First PostedOct 23, 2023
Enrollment StartNov 30, 2022
Primary CompletionAug 23, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 2.7 years ago